Fludarabine Phosphate (Sagent Pharmaceuticals)
Welcome to the PulseAid listing for the Fludarabine Phosphate drug offered from Sagent Pharmaceuticals. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sagent Pharmaceuticals |
| NON-PROPRIETARY NAME: | Fludarabine Phosphate |
| SUBSTANCE NAME: | FLUDARABINE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-02-01 |
| END MARKETING DATE: | 0000-00-00 |
Fludarabine Phosphate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Fludarabine Phosphate from Sagent Pharmaceuticals |
| LABELER NAME: | Sagent Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/2mL) |
| START MARKETING DATE: | 2009-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25021-205_8a25164b-70d9-4160-9b1e-2b665d405587 |
| PRODUCT NDC: | 25021-205 |
| APPLICATION NUMBER: | ANDA078610 |
Other FLUDARABINE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
